Profusa (PFSA) Return on Invested Capital (2022 - 2025)
Profusa's (PFSA) quarterly Return on Invested Capital came in at 0.0% in Q2 2025, up 33.75% quarter-over-quarter from 0.01% in Q1 2025.
Profusa (PFSA) Return on Invested Capital (2022 - 2025) Analysis & Trends
Profusa's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.0% for Q2 2025.
- On a quarterly basis, Return on Invested Capital changed N/A year-over-year to 0.0% in Q2 2025; TTM through Jun 2025 was 0.0%, a N/A change from a year earlier, with the FY2022 full-year figure at 0.9%, changed N/A from the prior year.
- Return on Invested Capital advanced to 0.0% in Q2 2025 per PFSA's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.0% in Q2 2025 and bottomed at 0.42% in Q4 2022.
- The 3-year median for Return on Invested Capital is 0.31% (2023), against an average of 0.23%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.01% |
| Sep 30, 2023 | -0.31% |
| Jun 30, 2023 | -0.34% |
| Mar 31, 2023 | -0.30% |
| Dec 31, 2022 | -0.42% |